Tuberculin skin test conversion in patientsunder treatment with anti-tumornecrotizing factor alpha agents

Tuberculin skin test conversion in patientsunder treatment with anti-tumornecrotizing factor alpha agents


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: علیرضا خبازی اسکویی , محمد اسمعیل حجازی , علی اصغر ابراهیمی چهارم , عاطفه احمدزاده , مریم فرمانی , یاسین حجازی

کلمات کلیدی: Tuberculin skin test, Anti-TNF-alpha agents, Tuberculosis

نشریه: 4980 , 464 , 20 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله علیرضا خبازی اسکویی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه بیماری های بافت همبند
کد مقاله 72769
عنوان فارسی مقاله Tuberculin skin test conversion in patientsunder treatment with anti-tumornecrotizing factor alpha agents
عنوان لاتین مقاله Tuberculin skin test conversion in patientsunder treatment with anti-tumornecrotizing factor alpha agents
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: Despite successful clinical outcomes of biologic medications in patients with chronic rheumatic diseases, some considerable adverse effects such as infections remain a major concern. Possibility of tuberculosis (TB) reactivation over treatment with anti-tumor necrotizing factor (TNF) alpha agents has necessitated a screening test before initiation of treatment. However, screening over the course of treatment is not recommended in those patients with negative baseline screening tests. This study aimed to evaluate the efficacy of tuberculin skin test (TST) before treatment in patients with chronic rheumatologic diseases who were indicated to receive anti-TNFalpha therapy and the necessity of repeating this test over the course of treatment. Methods: In this prospective study, patients with chronic rheumatologic diseases receiving anti-TNF-alpha agents were studied in a two-year period. TST was performed before treatment and those with positive results were excluded from the study. Thereafter, treatment with anti-TNF-alpha agents was initiated with the indicated dose. TST was repeated before administration of biologic treatment until TST became positive or 16 weeks after the initiation of treatment with anti-TNF-alpha. Results: A total of 51 cases were studied, of whom one patient (1.9%) was excluded due to positive TST before treatment. All participants received infliximab and the TST test became positive in one patient (2%) 2 weeks after receiving the first dose. Also, the results of further tests at weeks 6, 10, and 14 were all negative for the remaining patients. Conclusion: Due to the possibility of TST conversion after administration of anti-TNF-alpha therapy, it is important to consider TB monitoring in patients under treatment with these agents using available methods such as TST.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
علیرضا خبازی اسکوییسوم
محمد اسمعیل حجازیاول
علی اصغر ابراهیمی چهارمچهارم
عاطفه احمدزادهدوم
مریم فرمانیپنجم
یاسین حجازیششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Tuberculin skin test conversion in patients.pdf1399/04/13540953دانلود